Krauss, Gregory L <br/><br/>
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307.  [electronic resource] 

 -  Epilepsia  04 2018 
 - 866-876 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-1167 
<br/><br/><label>Standard No.: </label>10.1111/epi.14044  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticonvulsants--administration & dosage<br/>Dizziness--chemically induced<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Epilepsies, Partial--diagnosis<br/>Female<br/>Follow-Up Studies<br/>Headache--chemically induced<br/>Humans<br/>Nitriles<br/>Pyridones--administration & dosage<br/>Seizures--diagnosis<br/>Time Factors<br/>Treatment Outcome